XORTX Other Stockholder Equity vs Cash And Short Term Investments Analysis

XRTX Stock  USD 1.21  0.02  1.68%   
XORTX Therapeutics financial indicator trend analysis is more than just analyzing XORTX Therapeutics current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XORTX Therapeutics is a good investment. Please check the relationship between XORTX Therapeutics Other Stockholder Equity and its Cash And Short Term Investments accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

Other Stockholder Equity vs Cash And Short Term Investments

Other Stockholder Equity vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of XORTX Therapeutics Other Stockholder Equity account and Cash And Short Term Investments. At this time, the significance of the direction appears to have weak relationship.
The correlation between XORTX Therapeutics' Other Stockholder Equity and Cash And Short Term Investments is 0.32. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of XORTX Therapeutics, assuming nothing else is changed. The correlation between historical values of XORTX Therapeutics' Other Stockholder Equity and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of XORTX Therapeutics are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Stockholder Equity i.e., XORTX Therapeutics' Other Stockholder Equity and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.32
Relationship DirectionPositive 
Relationship StrengthVery Weak

Other Stockholder Equity

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of XORTX Therapeutics balance sheet. This account contains XORTX Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by XORTX Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from XORTX Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XORTX Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.Selling General Administrative is likely to drop to about 996.5 K in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Reconciled Depreciation17.9K55.5K139.7K146.7K
Research Development669.1K6.5M2.4M1.6M

XORTX Therapeutics fundamental ratios Correlations

-0.070.820.98-0.27-0.99-0.50.530.990.90.990.760.620.340.891.0-0.35-0.43-0.740.910.22-0.620.560.97-0.150.97
-0.070.35-0.13-0.750.140.00.35-0.14-0.14-0.14-0.16-0.08-0.20.14-0.060.0-0.050.21-0.17-0.55-0.410.28-0.120.25-0.09
0.820.350.8-0.51-0.81-0.140.440.810.60.810.350.240.220.770.83-0.09-0.17-0.340.62-0.3-0.50.370.810.190.84
0.98-0.130.8-0.23-0.98-0.490.390.980.880.980.710.610.440.80.98-0.38-0.45-0.750.920.19-0.580.560.93-0.170.99
-0.27-0.75-0.51-0.230.20.41-0.33-0.21-0.31-0.21-0.14-0.35-0.35-0.31-0.260.210.280.25-0.310.190.56-0.52-0.150.19-0.29
-0.990.14-0.81-0.980.20.44-0.51-1.0-0.88-1.0-0.73-0.57-0.32-0.88-0.990.310.380.7-0.89-0.230.54-0.48-0.980.12-0.97
-0.50.0-0.14-0.490.410.44-0.36-0.43-0.72-0.43-0.77-0.98-0.61-0.37-0.470.690.760.87-0.76-0.580.77-0.87-0.310.8-0.48
0.530.350.440.39-0.33-0.51-0.360.510.550.510.670.38-0.330.830.52-0.15-0.23-0.30.330.28-0.570.440.580.110.34
0.99-0.140.810.98-0.21-1.0-0.430.510.881.00.730.570.320.890.99-0.3-0.37-0.70.880.23-0.540.480.98-0.110.97
0.9-0.140.60.88-0.31-0.88-0.720.550.880.880.880.790.460.80.88-0.4-0.48-0.870.920.55-0.630.70.83-0.340.85
0.99-0.140.810.98-0.21-1.0-0.430.511.00.880.730.570.320.890.99-0.3-0.37-0.70.880.23-0.540.480.98-0.110.97
0.76-0.160.350.71-0.14-0.73-0.770.670.730.880.730.820.20.740.74-0.59-0.65-0.780.780.62-0.720.770.7-0.350.65
0.62-0.080.240.61-0.35-0.57-0.980.380.570.790.570.820.620.470.6-0.7-0.77-0.910.850.57-0.780.850.45-0.780.6
0.34-0.20.220.44-0.35-0.32-0.61-0.330.320.460.320.20.62-0.040.32-0.38-0.41-0.630.660.19-0.310.460.14-0.750.5
0.890.140.770.8-0.31-0.88-0.370.830.890.80.890.740.47-0.040.89-0.18-0.27-0.540.680.22-0.580.460.930.080.78
1.0-0.060.830.98-0.26-0.99-0.470.520.990.880.990.740.60.320.89-0.35-0.42-0.710.890.18-0.610.540.97-0.130.97
-0.350.0-0.09-0.380.210.310.69-0.15-0.3-0.4-0.3-0.59-0.7-0.38-0.18-0.350.990.49-0.53-0.170.75-0.77-0.20.53-0.36
-0.43-0.05-0.17-0.450.280.380.76-0.23-0.37-0.48-0.37-0.65-0.77-0.41-0.27-0.420.990.58-0.61-0.20.83-0.84-0.270.56-0.43
-0.740.21-0.34-0.750.250.70.87-0.3-0.7-0.87-0.7-0.78-0.91-0.63-0.54-0.710.490.58-0.91-0.620.61-0.71-0.60.65-0.73
0.91-0.170.620.92-0.31-0.89-0.760.330.880.920.880.780.850.660.680.89-0.53-0.61-0.910.38-0.680.70.79-0.530.92
0.22-0.55-0.30.190.19-0.23-0.580.280.230.550.230.620.570.190.220.18-0.17-0.2-0.620.38-0.070.260.2-0.480.11
-0.62-0.41-0.5-0.580.560.540.77-0.57-0.54-0.63-0.54-0.72-0.78-0.31-0.58-0.610.750.830.61-0.68-0.07-0.94-0.470.39-0.58
0.560.280.370.56-0.52-0.48-0.870.440.480.70.480.770.850.460.460.54-0.77-0.84-0.710.70.26-0.940.38-0.480.54
0.97-0.120.810.93-0.15-0.98-0.310.580.980.830.980.70.450.140.930.97-0.2-0.27-0.60.790.2-0.470.380.040.91
-0.150.250.19-0.170.190.120.80.11-0.11-0.34-0.11-0.35-0.78-0.750.08-0.130.530.560.65-0.53-0.480.39-0.480.04-0.21
0.97-0.090.840.99-0.29-0.97-0.480.340.970.850.970.650.60.50.780.97-0.36-0.43-0.730.920.11-0.580.540.91-0.21
Click cells to compare fundamentals

XORTX Therapeutics Account Relationship Matchups

XORTX Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.1M2.3M17.3M12.3M5.5M5.0M
Other Current Liab641.5K728.4K229.0K151.4K87.6K83.2K
Total Current Liabilities1.3M1.0M4.2M1.5M294.9K280.2K
Total Stockholder Equity(211.7K)1.3M13.1M7.0M4.6M3.1M
Property Plant And Equipment Net731.0341.00.092.5K23.9K28.8K
Net Debt(7.8K)(171.3K)(14.8M)(10.3M)(3.4M)(3.6M)
Retained Earnings(6.8M)(8.0M)(7.6M)(14.1M)(23.7M)(22.5M)
Accounts Payable607.4K305.8K324.0K1.3M195.8K186.0K
Cash58.6K171.3K14.8M10.4M3.4M3.6M
Non Current Assets Total272.7K234.3K1.5M1.5M1.4M731.9K
Cash And Short Term Investments58.6K171.3K14.8M10.4M3.4M3.6M
Net Receivables15.5K14.4K40.7K81.8K60.7K35.1K
Common Stock Shares Outstanding595.5K740.4K1.1M1.5M2.0M2.1M
Liabilities And Stockholders Equity1.1M2.3M17.3M12.3M5.5M5.0M
Other Stockholder Equity683.0K0.05.0M(2.1M)5.8M6.1M
Total Liab1.3M1.0M4.2M5.4M825.9K784.6K
Total Current Assets815.2K2.1M15.8M10.9M4.1M4.2M
Short Long Term Debt Total272.5K43.3K50.8K77.4K11.5K10.9K
Intangible Assets272.4K234.3K201.0K199.4K175.3K189.0K
Net Tangible Assets(484.1K)1.0M16.5M9.2M10.6M11.1M
Net Invested Capital(160.9K)1.3M16.7M7.0M4.6M4.6M
Net Working Capital(484.5K)1.0M14.9M9.4M3.8M4.3M
Other Current Assets741.2K1.9M1.0M379.6K560.4K701.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.